Background: Growth differentiation factor 15 (GDF15), induced by tissue inflammation and mitochondrial stress, has received significant attention as a biomarker of mitochondrial dysfunction and has been implicated in various age-related diseases. However, the association between circulating GDF15 and sarcopenia-associated outcomes in older adults remains to be established. Aim: To validate previous experimental data and to investigate the possible role of GDF15 in aging and muscle physiology in humans, this study examined serum GDF15 levels in relation to sarcopenia-related parameters in a cohort of older Asian adults. Methods: Muscle mass and muscle function-related parameters, such as grip strength, gait speed, chair stands, and short physical performance battery score were evaluated by experienced nurses in 125 geriatric participants with or without sarcopenia. Sarcopenia was diagnosed using the Asian-specific cutoff points. Serum GDF15 levels were measured using an enzyme immunoassay kit. Results: Serum GDF15 levels were not significantly different according to sarcopenia status, muscle mass, muscle strength, and physical performance and were not associated with the skeletal muscle index, grip strength, gait speed, time to complete 5 chair stands, and short physical performance battery score, regardless of adjustments for sex, age, and BMI. Conclusions: These findings indicate that the definite role of GDF15 on muscle metabolism observed in animal models might not be evident in humans and that elevated GDF15 levels might not predict the risk for sarcopenia, at least in older Asian adults.

1.
Larsson
L
,
Degens
H
,
Li
M
,
Salviati
L
,
Lee
YI
,
Thompson
W
,
Sarcopenia: aging-related loss of muscle mass and function
.
Physiol Rev
.
2019
;
99
(
1
):
427
511
. .
2.
Santilli
V
,
Bernetti
A
,
Mangone
M
,
Paoloni
M
.
Clinical definition of sarcopenia
.
Clin Cases Miner Bone Metab
.
2014
;
11
(
3
):
177
80
..
3.
Abellan van Kan
G
.
Epidemiology and consequences of sarcopenia
.
J Nutr Health Aging
.
2009
;
13
(
8
):
708
12
. .
4.
Kwan
P
.
Sarcopenia, a neurogenic syndrome?
J Aging Res
.
2013
;
2013
:
791679
. .
5.
Short
KR
,
Bigelow
ML
,
Kahl
J
,
Singh
R
,
Coenen-Schimke
J
,
Raghavakaimal
S
,
Decline in skeletal muscle mitochondrial function with aging in humans
.
Proc Natl Acad Sci USA
.
2005
;
102
(
15
):
5618
23
. .
6.
Marzetti
E
,
Calvani
R
,
Cesari
M
,
Buford
TW
,
Lorenzi
M
,
Behnke
BJ
,
Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials
.
Int J Biochem Cell Biol
.
2013
;
45
(
10
):
2288
301
. .
7.
Rooyackers
OE
,
Adey
DB
,
Ades
PA
,
Nair
KS
.
Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle
.
Proc Natl Acad Sci USA
.
1996
;
93
(
26
):
15364
9
. .
8.
Alway
SE
,
Mohamed
JS
,
Myers
MJ
.
Mitochondria initiate and regulate sarcopenia
.
Exerc Sport Sci Rev
.
2017
;
45
(
2
):
58
69
. .
9.
Muoio
DM
,
Neufer
PD
.
Lipid-induced mitochondrial stress and insulin action in muscle
.
Cell Metab
.
2012
;
15
(
5
):
595
605
. .
10.
Moon
SS
.
Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009–2010
.
Endocr J
.
2014
;
61
(
1
):
61
70
.
11.
Yi
HS
,
Chang
JY
,
Shong
M
.
The mitochondrial unfolded protein response and mitohormesis: a perspective on metabolic diseases
.
J Mol Endocrinol
.
2018
;
61
(
3
):
R91
R105
. .
12.
Khan
NA
,
Nikkanen
J
,
Yatsuga
S
,
Jackson
C
,
Wang
L
,
Pradhan
S
,
mTORC1 regulates mitochondrial integrated stress response and mitochondrial myopathy progression
.
Cell Metab
.
2017
;
26
(
2
):
419
e5
. .
13.
Yi
HS
.
Implications of mitochondrial unfolded protein response andmMitokines: a perspective on fatty liver diseases
.
Endocrinol Metab
.
2019
;
34
(
1
):
39
46
. .
14.
Lane
RK
,
Hilsabeck
T
,
Rea
SL
.
The role of mitochondrial dysfunction in age-related diseases
.
Biochim Biophys Acta
.
2015
;
1847
(
11
):
1387
400
. .
15.
Chrysovergis
K
,
Wang
X
,
Kosak
J
,
Lee
SH
,
Kim
JS
,
Foley
JF
,
NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism
.
Int J Obes
.
2014
;
38
(
12
):
1555
64
. .
16.
Chung
HK
,
Kim
JT
,
Kim
HW
,
Kwon
M
,
Kim
SY
,
Shong
M
,
GDF15 deficiency exacerbates chronic alcohol- and carbon tetrachloride-induced liver injury
.
Sci Rep
.
2017
;
7
(
1
):
17238
. .
17.
Chung
HK
,
Ryu
D
,
Kim
KS
,
Chang
JY
,
Kim
YK
,
Yi
HS
,
Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis
.
J Cell Biol
.
2017
;
216
(
1
):
149
65
. .
18.
Semba
RD
,
Gonzalez-Freire
M
,
Tanaka
T
,
Biancotto
A
,
Zhang
P
,
Shardell
M
,
Elevated plasma growth and differentiation factor 15 is associated with slower gait speed and lower physical performance in healthy community-dwelling adults
.
J Gerontol A Biol Sci Med Sci
.
2020
;
75
(
1
):
175
80
. .
19.
Oh
JH
,
Song
S
,
Rhee
H
,
Lee
SH
,
Kim
DY
,
Choe
JC
,
Erratum: correction of figure in the article: normal reference plots for the bioelectrical impedance vector in healthy korean adults
.
J Korean Med Sci
.
2019
;
34
(
35
):
e242
. .
20.
Jang
IY
,
Jung
HW
,
Lee
CK
,
Yu
SS
,
Lee
YS
,
Lee
E
.
Comparisons of predictive values of sarcopenia with different muscle mass indices in Korean rural older adults: a longitudinal analysis of the aging study of PyeongChang rural area
.
Clin Interv Aging
.
2018
;
13
:
91
9
. .
21.
Roberts
HC
,
Denison
HJ
,
Martin
HJ
,
Patel
HP
,
Syddall
H
,
Cooper
C
,
A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach
.
Age Ageing
.
2011
;
40
(
4
):
423
9
. .
22.
Peel
NM
,
Kuys
SS
,
Klein
K
.
Gait speed as a measure in geriatric assessment in clinical settings: a systematic review
.
J Gerontol A Biol Sci Med Sci
.
2013
;
68
(
1
):
39
46
. .
23.
Jung
HW
,
Roh
H
,
Cho
Y
,
Jeong
J
,
Shin
YS
,
Lim
JY
,
Validation of a multi-sensor-based kiosk for short physicalperformance battery
.
J Am Geriatr Soc
.
2019
;
67
(
12
):
2605
9
. .
24.
Chen
LK
,
Woo
J
,
Assantachai
P
,
Auyeung
TW
,
Chou
MY
,
Iijima
K
,
Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment
.
J Am Med Dir Assoc
.
2020
;
21
(
3
):
300
e2
. .
25.
Nakajima
T
,
Shibasaki
I
,
Sawaguchi
T
,
Haruyama
A
,
Kaneda
H
,
Nakajima
T
,
Growth differentiation factor-15 (GDF-15) is a biomarker of muscle wasting and renal dysfunction in preoperative cardiovascular surgery patients
.
J Clin Med
.
2019
;
8
(
10
):
1576
. .
26.
Ost
M
,
Igual Gil
C
,
Coleman
V
,
Keipert
S
,
Efstathiou
S
,
Vidic
V
,
Muscle-derived GDF15 drives diurnal anorexia and systemic metabolic remodeling during mitochondrial stress
.
EMBO Rep
.
2020
;
21
(
3
):
e48804
. .
27.
Bloch
SA
,
Lee
JY
,
Syburra
T
,
Rosendahl
U
,
Griffiths
MJ
,
Kemp
PR
,
Increased expression of GDF-15 may mediate ICU-acquired weakness by down-regulating muscle microRNAs
.
Thorax
.
2015
;
70
(
3
):
219
28
. .
28.
Moon
JS
,
Goeminne
LJE
,
Kim
JT
,
Tian
JW
,
Kim
SH
,
Nga
HT
,
Growth differentiation factor 15 protects against the aging-mediated systemic inflammatory response in humans and mice
.
Aging cell
.
2020
;
19
(
8
):
e13195
. .
29.
Tanaka
T
,
Biancotto
A
,
Moaddel
R
,
Moore
AZ
,
Gonzalez-Freire
M
,
Aon
MA
,
Plasma proteomic signature of age in healthy humans
.
Aging cell
.
2018
;
17
(
5
):
e12799
. .
30.
Conte
M
,
Ostan
R
,
Fabbri
C
,
Santoro
A
,
Guidarelli
G
,
Vitale
G
,
Human aging and longevity are characterized by high levels of mitokines
.
J Gerontol A Biol Sci Med Sci
.
2019
;
74
(
5
):
600
7
. .
31.
Lehallier
B
,
Gate
D
,
Schaum
N
,
Nanasi
T
,
Lee
SE
,
Yousef
H
,
Undulating changes in human plasma proteome profiles across the lifespan
.
Nat Med
.
2019
;
25
(
12
):
1843
50
. .
32.
Conte
M
,
Martucci
M
,
Mosconi
G
,
Chiariello
A
,
Cappuccilli
M
,
Totti
V
,
GDF15 plasma level is inversely associated with level of physical activity and correlates with markers of inflammation and muscle weakness
.
Front Immunol
.
2020
;
11
:
915
. .
33.
Coll
AP
,
Chen
M
,
Taskar
P
,
Rimmington
D
,
Patel
S
,
Tadross
JA
,
GDF15 mediates the effects of metformin on body weight and energy balance
.
Nature
.
2020
;
578
(
7795
):
444
8
. .
34.
Melvin
A
,
Chantzichristos
D
,
Kyle
CJ
,
Mackenzie
SD
,
Walker
BR
,
Johannsson
G
,
GDF15 is elevated in conditions of glucocorticoid deficiency and is modulated by glucocorticoid replacement
.
J Clin Endocrinol Metab
.
2020
;
105
(
5
). .
35.
Brown
JB
,
Celniker
SE
.
Lessons from modENCODE
.
Annu Rev Genomics Hum Genet
.
2015
;
16
:
31
53
. .
36.
Yue
F
,
Cheng
Y
,
Breschi
A
,
Vierstra
J
,
Wu
W
,
Ryba
T
,
A comparative encyclopedia of DNA elements in the mouse genome
.
Nature
.
2014
;
515
(
7527
):
355
64
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.